Gardner Expands Compliance and Litigation Capabilities with Addition of Vivian Egbu

Gardner Law is pleased to announce that Vivian Egbu has joined the firm, further strengthening our compliance, enforcement, and litigation capabilities for companies in FDA-regulated industries.

Vivian advises FDA-regulated companies on healthcare compliance, enforcement risk, government investigations, regulatory matters, and complex disputes across the product life cycle. She brings prior experience as an Assistant Attorney General, giving clients insight into how regulators and enforcement agencies evaluate risk, conduct investigations, coordinate across agencies, and pursue enforcement strategies.

Vivian’s background is particularly valuable for companies facing issues that sit at the intersection of compliance, enforcement, reimbursement, and litigation. Her experience includes healthcare fraud litigation, whistleblower matters, administrative proceedings, Medicaid and government program enforcement, licensing and sanctions disputes, reimbursement issues, FDA-related enforcement matters, and regulatory enforcement actions involving pharmaceutical companies, manufacturers, hospitals, medical providers, drug companies, and medical device companies. She is also Certified in Healthcare Compliance (CHC), bringing an additional practical perspective on how enforcement risk should inform compliance strategy and program design.

For Gardner Law clients, Vivian’s arrival expands the firm’s ability to help companies prepare for government scrutiny, respond strategically when issues escalate, and design compliance programs informed by real-world enforcement priorities.

Her experience strengthens Gardner Law’s ability to support clients with:

• Government investigation readiness
• FDA enforcement actions and response strategy
• Enforcement-driven compliance strategy
• Healthcare fraud litigation and enforcement matters
• Whistleblower, Anti-Kickback Statute, and False Claims Act case mechanics
• Administrative law and agency proceedings
• Medicaid and government program enforcement
• Reimbursement, payer, licensing, and sanctions disputes
• Strategic defense positioning when issues escalate

Vivian’s addition reflects Gardner Law’s continued growth as a practical, business-oriented legal resource for companies operating in FDA-regulated industries. Clients increasingly need counsel that can support them across the full product life cycle, from regulatory strategy and compliance program design to investigations, enforcement response, litigation, commercial disputes, privacy, and operational risk.

“Vivian brings exactly the kind of real-world enforcement perspective our clients need. She has handled healthcare fraud, whistleblower, Medicaid, licensing, sanctions, and administrative enforcement matters from inside government, and she understands how agencies evaluate risk and how investigations develop. Vivian gives our clients a stronger advocate when scrutiny intensifies, and she is an important addition to Gardner Law as we continue building our compliance, enforcement, and litigation capabilities.”

Mark Gardner, Founder & Managing Partner

Learn more about Vivian by visiting her profile on our team page.

Vivian will also participate in Gardner Law’s May 14 program, Marking Ten Years: Past, Present, and Future Perspectives in FDA Law, during a discussion on litigation and government enforcement strategy.